{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:10Z","timestamp":1786979890654,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T00:00:00Z","timestamp":1334275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Abdom Imaging"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00261-012-9845-y","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T03:48:14Z","timestamp":1334202494000},"page":"983-1003","source":"Crossref","is-referenced-by-count":41,"title":["Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumors"],"prefix":"10.1007","volume":"37","author":[{"given":"Anna Maria","family":"De Gaetano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Rufini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Filograna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,13]]},"reference":[{"key":"9845_CR1","first-page":"1771","volume":"40","author":"WA Weber","year":"1999","unstructured":"Weber WA, Ziegler SI, Thodtmann R, Hanauske AR, Schwaiger M (1999) Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 40:1771\u20131777","journal-title":"J Nucl Med"},{"key":"9845_CR2","first-page":"82S","volume":"45","author":"RL Wahl","year":"2004","unstructured":"Wahl RL (2004) Why nearly all PET of abdominal and pelvic cancers will be performed as PET\/CT. J Nucl Med 45:82S\u201395S","journal-title":"J Nucl Med"},{"issue":"5","key":"9845_CR3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archsurg.133.5.510","volume":"133","author":"D Delbeke","year":"1998","unstructured":"Delbeke D, Martin WH, Sandler MP, et al. (1998) Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 133(5):510\u2013515","journal-title":"Arch Surg"},{"issue":"1","key":"9845_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cncr.10309","volume":"96","author":"RL Zimmerman","year":"2002","unstructured":"Zimmerman RL, Burke M, Young NA, Solomides CC, Bibbo M (2002) Diagnostic utility of Glut-1 and CA 15\u20133 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration. Cancer 96(1):53\u201357","journal-title":"Cancer"},{"issue":"10","key":"9845_CR5","first-page":"1811","volume":"36","author":"T Torizuka","year":"1995","unstructured":"Torizuka T, Tamaki N, Inokuma T, et al. (1995) In vivo assessment of glucose metabolism in hepatocellular carcinoma with [18F]FDG-PET. J Nucl Med 36(10):1811\u20131817","journal-title":"J Nucl Med"},{"key":"9845_CR6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0168-8278(00)80248-2","volume":"32","author":"MA Khan","year":"2000","unstructured":"Khan MA, Combs CS, Brunt EM, et al. (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792\u2013797","journal-title":"J Hepatol"},{"key":"9845_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02988591","volume":"14","author":"Y Iwata","year":"2000","unstructured":"Iwata Y, Shiomi S, Sasaki N, et al. (2000) Clinical usefulness of positron emission tomography scanning with fluorine- 18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med 14:121\u2013126","journal-title":"Ann Nucl Med"},{"key":"9845_CR8","first-page":"546","volume":"12","author":"JA Shin","year":"2006","unstructured":"Shin JA, Park JW, An M, et al. (2006) Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma. Korean J Hepatol 12:546\u2013552","journal-title":"Korean J Hepatol"},{"key":"9845_CR9","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2001.03888.x","volume":"96","author":"S Shiomi","year":"2001","unstructured":"Shiomi S, Nishiguchi S, Ishizu H, et al. (2001) Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol 96:1877\u20131880","journal-title":"Am J Gastroenterol"},{"key":"9845_CR10","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00259-004-1602-1","volume":"31","author":"JD Lee","year":"2004","unstructured":"Lee JD, Yun M, Lee JM, et al. (2004) Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography. Eur J Nucl Med Mol Imaging 31:1621\u20131630","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9845_CR11","first-page":"213","volume":"44","author":"CL Ho","year":"2003","unstructured":"Ho CL, Yu SC, Yeung DW (2003) [11C]-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44:213\u2013221","journal-title":"J Nucl Med"},{"key":"9845_CR12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1478-3231.2006.01335.x","volume":"26","author":"S Li","year":"2006","unstructured":"Li S, Beheshti M, Peck-Radosavljevic M, et al. (2006) Comparison of (11) C-acetate positron emission tomography and (67) Gallium citrate scintigraphy in patients with hepatocellular carcinoma. Liver Int 26:920\u2013927","journal-title":"Liver Int"},{"key":"9845_CR13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.apradiso.2009.02.011","volume":"67","author":"KH Hwang","year":"2009","unstructured":"Hwang KH, Choi DJ, Lee SY, Lee MK, Choe W (2009) Evaluation of patients with hepatocellular carcinomas using [11C]acetate and [18F]FDG PET\/CT: A preliminary study. Appl Radiat Isot 67:1195\u20131198","journal-title":"Appl Radiat Isot"},{"issue":"8","key":"9845_CR14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2967\/jnumed.108.052639","volume":"49","author":"Y Yamamoto","year":"2008","unstructured":"Yamamoto Y, Nishiyama Y, Kameyama R, et al. (2008) Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. J Nucl Med 49(8):1245\u20131248","journal-title":"J Nucl Med"},{"key":"9845_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1158\/1078-0432.CCR-06-1357","volume":"13","author":"S Seo","year":"2007","unstructured":"Seo S, Hatano E, Higashi T, et al. (2007) Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 13:427\u2013433","journal-title":"Clin Cancer Res"},{"key":"9845_CR16","first-page":"279","volume":"10","author":"YH Kong","year":"2004","unstructured":"Kong YH, Han CJ, Lee SD, et al. (2004) Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma. Korean J Hepatol 10:279\u2013287","journal-title":"Korean J Hepatol"},{"key":"9845_CR17","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/lt.20861","volume":"12","author":"SH Yang","year":"2006","unstructured":"Yang SH, Suh KS, Lee HW, et al. (2006) The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 12:1655\u20131660","journal-title":"Liver Transpl"},{"key":"9845_CR18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/lt.22069","volume":"16","author":"YK Kim","year":"2010","unstructured":"Kim YK, Lee KW, Cho SY, et al. (2010) Usefulness 18F-FDG positron emission tomography\/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Liver transplantation 16:767\u2013772","journal-title":"Liver transplantation"},{"issue":"1","key":"9845_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4254\/wjh.v1.i1.90","volume":"1","author":"L Sun","year":"2009","unstructured":"Sun L, Guan YS, Pan WM, et al. (2009) Metabolic restaging of hepatocellular carcinoma using whole-body 18F-FDG PET\/CT. World J Hepatol 1(1):90\u201397","journal-title":"World J Hepatol"},{"issue":"12","key":"9845_CR20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2967\/jnumed.110.079244","volume":"51","author":"HO Kim","year":"2010","unstructured":"Kim HO, Kim JS, Shin YM, et al. (2010) Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET\/CT. J Nucl Med 51(12):1849\u20131856","journal-title":"J Nucl Med"},{"key":"9845_CR21","first-page":"1965","volume":"35","author":"T Torizuka","year":"1994","unstructured":"Torizuka T, Tamaki N, Inokuma T, et al. (1994) Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 35:1965\u20131969","journal-title":"J Nucl Med"},{"key":"9845_CR22","first-page":"4719","volume":"25","author":"YK Chen","year":"2005","unstructured":"Chen YK, Hsieh DS, Liao CS, et al. (2005) Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence. Anticancer Res 25:4719\u20134725","journal-title":"Anticancer Res"},{"issue":"3","key":"9845_CR23","first-page":"192","volume":"28","author":"GS Anderson","year":"2003","unstructured":"Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H (2003) FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 28(3):192\u2013197","journal-title":"Clin Nucl Med"},{"key":"9845_CR24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00535-004-1427-5","volume":"39","author":"M Sugiyama","year":"2004","unstructured":"Sugiyama M, Sakahara H, Torizuka T, et al. (2004) 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol 39:961\u2013968","journal-title":"J Gastroenterol"},{"key":"9845_CR25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1478-3231.2006.01296.x","volume":"26","author":"S Nagaoka","year":"2006","unstructured":"Nagaoka S, Itano S, Ishibashi M, et al. (2006) Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver Int 26:781\u2013788","journal-title":"Liver Int"},{"issue":"2","key":"9845_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1872-034X.2008.00416.x","volume":"39","author":"T Kawaoka","year":"2009","unstructured":"Kawaoka T, Aikata H, Takaki S, et al. (2009) FDG positron emission tomography\/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma. Hepatol Res 39(2):134\u2013142","journal-title":"Hepatol Res"},{"key":"9845_CR27","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.3748\/wjg.v13.i40.5413","volume":"13","author":"L Sun","year":"2007","unstructured":"Sun L, Guan YS, Pan WM, et al. (2007) Positron emission tomography\/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management. World J Gastroenterol 13:5413\u20135415","journal-title":"World J Gastroenterol"},{"key":"9845_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4065\/70.5.425","volume":"70","author":"DR Farley","year":"1995","unstructured":"Farley DR, Weaver AL, Nagorney DM (1995) \u2018\u2018Natural history\u2019\u2019 of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 70:425\u2013429","journal-title":"Mayo Clin Proc"},{"key":"9845_CR29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507\u2013517","journal-title":"Ann Surg"},{"issue":"5","key":"9845_CR30","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/jhep.2001.23912","volume":"33","author":"R Kluge","year":"2001","unstructured":"Kluge R, Schmidt F, Caca K, et al. (2001) Positron emission tomography with [(18)F]fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer. Hepatology 33(5):1029\u20131035","journal-title":"Hepatology"},{"key":"9845_CR31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1440-1746.2007.05173.x","volume":"23","author":"CM Moon","year":"2008","unstructured":"Moon CM, Bang S, Chung JB, et al. (2008) Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol 23:759\u2013765","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"9845_CR32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","volume":"206","author":"CU Corvera","year":"2008","unstructured":"Corvera CU, Blumgart LH, Akhurst T, et al. (2008) 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206(1):57\u201365","journal-title":"J Am Coll Surg"},{"issue":"1","key":"9845_CR33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gassur.2003.10.003","volume":"8","author":"CD Anderson","year":"2004","unstructured":"Anderson CD, Rice MH, Pinson CW, et al. (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8(1):90\u201397","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"9845_CR34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00259-002-0852-z","volume":"29","author":"T Kato","year":"2002","unstructured":"Kato T, Tsukamoto E, Kuge Y, et al. (2002) Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 29(8):1047\u20131054","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9845_CR35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00006231-200112000-00002","volume":"22","author":"A Fritscher-Ravens","year":"2001","unstructured":"Fritscher-Ravens A, Bohuslavizki KH, Broering DC, et al. (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277\u20131285","journal-title":"Nucl Med Commun"},{"issue":"1","key":"9845_CR36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","volume":"45","author":"H Petrowsky","year":"2006","unstructured":"Petrowsky H, Wildbrett P, Husarik DB, et al. (2006) Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45(1):43\u201350","journal-title":"J Hepatol"},{"issue":"5","key":"9845_CR37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1572-0241.2007.01710.x","volume":"103","author":"JY Kim","year":"2008","unstructured":"Kim JY, Kim MH, Lee TY, et al. (2008) Clinical role of 18F-FDG PET\u2013CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol 103(5):1145\u20131151","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"9845_CR38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0212-6982(09)70701-3","volume":"28","author":"C Ramos-Font","year":"2009","unstructured":"Ramos-Font C, Santiago Chinchilla A, Rodr\u00edguez-Fern\u00e1ndez A, et al. (2009) Gallbladder cancer staging with 18F-FDG PET\u2013CT. Rev Esp Med Nucl 28(2):74\u201377","journal-title":"Rev Esp Med Nucl"},{"issue":"2","key":"9845_CR39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.amjsurg.2003.12.070","volume":"188","author":"A Rodr\u00edguez-Fern\u00e1ndez","year":"2004","unstructured":"Rodr\u00edguez-Fern\u00e1ndez A, G\u00f3mez-R\u00edo M, Llamas-Elvira JM, et al. (2004) Positron-emission tomography with fluorine-18-fluoro-2-deoxy-d-glucose for gallbladder cancer diagnosis. Am J Surg 188(2):171\u2013175","journal-title":"Am J Surg"},{"issue":"3","key":"9845_CR40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.206.3.9494497","volume":"206","author":"H Abdel-Nabi","year":"1998","unstructured":"Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206(3):755\u2013760","journal-title":"Radiology"},{"issue":"3","key":"9845_CR41","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejso.2003.10.023","volume":"30","author":"TH Arulampalam","year":"2004","unstructured":"Arulampalam TH, Francis DL, Visvikis D, Taylor I, Ell PJ (2004) FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 30(3):286\u2013291","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"9845_CR42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/bjs.4843","volume":"92","author":"S Truant","year":"2005","unstructured":"Truant S, Huglo D, Hebbar M, et al. (2005) Prospective evaluation of the impact of [18F]fluoro-2-deoxy-d-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 92(3):362\u2013369","journal-title":"Br J Surg"},{"issue":"7","key":"9845_CR43","first-page":"1177","volume":"41","author":"RH Huebner","year":"2000","unstructured":"Huebner RH, Park KC, Shepherd JE, et al. (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41(7):1177\u20131189","journal-title":"J Nucl Med"},{"issue":"3","key":"9845_CR44","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1148\/radiol.2243011362","volume":"224","author":"K Kinkel","year":"2002","unstructured":"Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224(3):748\u2013756","journal-title":"Radiology"},{"key":"9845_CR45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiol.2371042060","volume":"237","author":"S Bipat","year":"2005","unstructured":"Bipat S, van Leeuwen MS, Comans EFI, et al. (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237:123\u2013131","journal-title":"Radiology"},{"issue":"6","key":"9845_CR46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.sla.0000146145.69835.c5","volume":"240","author":"M Selzner","year":"2004","unstructured":"Selzner M, Hany TF, Wildbrett P, et al. (2004) Does the novel PET\/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240(6):1027\u20131034","journal-title":"Ann Surg"},{"issue":"4","key":"9845_CR47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/02841850701294560","volume":"48","author":"ED Rappeport","year":"2007","unstructured":"Rappeport ED, Loft A, Berthelsen AK, et al. (2007) Contrast-enhanced FDG-PET\/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48(4):369\u2013378","journal-title":"Acta Radiol"},{"key":"9845_CR48","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1245\/s10434-011-1670-y","volume":"18","author":"E Ramos","year":"2011","unstructured":"Ramos E, Valls C, Martinez L, et al. (2011) Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET\/CT really add something to multidetector CT? Ann Surg Oncol 18:2654\u20132661","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"9845_CR49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9610(99)80067-1","volume":"171","author":"JV Vitola","year":"1996","unstructured":"Vitola JV, Delbeke D, Sandler MP, et al. (1996) Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171(1):21\u201326","journal-title":"Am J Surg"},{"issue":"2","key":"9845_CR50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.gassur.2003.11.009","volume":"8","author":"CM Sch\u00fcssler-Fiorenza","year":"2004","unstructured":"Sch\u00fcssler-Fiorenza CM, Mahvi DM, Niederhuber J, Rikkers LF, Weber SM (2004) Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases. J Gastrointest Surg 8(2):150\u2013157","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"9845_CR51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1148\/rg.311105033","volume":"31","author":"NC Purandare","year":"2011","unstructured":"Purandare NC, Rangarajan V, Shah SA, et al. (2011) Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET\/CT findings. Radiographics 31(1):201\u2013213","journal-title":"Radiographics"},{"key":"9845_CR52","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF02238010","volume":"43","author":"MH Whiteford","year":"2000","unstructured":"Whiteford MH, Whiteford HM, Ogunbiyi OA, et al. (2000) Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43:759\u2013770","journal-title":"Dis Colon Rectum"},{"key":"9845_CR53","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2214\/ajr.174.4.1741005","volume":"174","author":"KL Berger","year":"2000","unstructured":"Berger KL, Nicholson SA, Dehdashti F, Siegel BA (2000) FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR 174:1005\u20131008","journal-title":"AJR"},{"key":"9845_CR54","first-page":"1972","volume":"33","author":"R Kubota","year":"1992","unstructured":"Kubota R, Yamada S, Kubota K, et al. (1992) Intratumoral distribution of F18-fluoro-deoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by micro-autoradiography. J Nucl Med 33:1972\u20131980","journal-title":"J Nucl Med"},{"issue":"97","key":"9845_CR55","first-page":"138","volume":"57","author":"M Donadon","year":"2010","unstructured":"Donadon M, Bona S, Montorsi M, Torzilli G (2010) FDG-PET positive granuloma of the liver mimicking local recurrence after hepatic resection of colorectal liver metastasis. Hepatogastroenterology 57(97):138\u2013139","journal-title":"Hepatogastroenterology"},{"issue":"34","key":"9845_CR56","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.1200\/JCO.2005.04.4222","volume":"23","author":"T Akhurst","year":"2005","unstructured":"Akhurst T, Kates TJ, Mazumdar M, et al. (2005) Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 23(34):8713\u20138716","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"9845_CR57","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.2967\/jnumed.108.057224","volume":"50","author":"LF Geus-Oei de","year":"2009","unstructured":"de Geus-Oei LF, Vriens D, van Laarhoven HW, van der Graaf WT, Oyen WJ (2009) Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. J Nucl Med 50(Suppl 1):43S\u201354S","journal-title":"J Nucl Med"},{"key":"9845_CR58","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1053\/j.gastro.2005.03.035","volume":"128","author":"CJ Wray","year":"2005","unstructured":"Wray CJ, Ahmad SA, Matthews JB, Lowy AM (2005) Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 128:1626\u20131641","journal-title":"Gastroenterology"},{"key":"9845_CR59","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/bjs.4484","volume":"91","author":"M Wagner","year":"2004","unstructured":"Wagner M, Redaelli C, Lietz M, et al. (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586\u2013594","journal-title":"Br J Surg"},{"key":"9845_CR60","first-page":"1344","volume":"38","author":"SN Reske","year":"1997","unstructured":"Reske SN, Grillenberger KG, Glatting G, et al. (1997) Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med 38:1344\u20131348","journal-title":"J Nucl Med"},{"key":"9845_CR61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.semnuclmed.2006.03.005","volume":"36","author":"F Pakzad","year":"2006","unstructured":"Pakzad F, Groves AM, Ell PJ (2006) The role of positron emission tomography in the management of pancreatic cancer. Semin Nucl Med 36:248\u2013256","journal-title":"Semin Nucl Med"},{"key":"9845_CR62","first-page":"1727","volume":"39","author":"T Higashi","year":"1998","unstructured":"Higashi T, Tamaki N, Torizuka T, et al. (1998) FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med 39:1727\u20131735","journal-title":"J Nucl Med"},{"key":"9845_CR63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00006676-200003000-00001","volume":"20","author":"CG Diederichs","year":"2000","unstructured":"Diederichs CG, Staib L, Vogel J, et al. (2000) Values and limitations of 18F-fluorodeoxyglucose positron emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20:109\u2013116","journal-title":"Pancreas"},{"issue":"suppl 5","key":"9845_CR64","first-page":"1S","volume":"42","author":"SS Gambhir","year":"2001","unstructured":"Gambhir SS, Czernin J, Schwimmer J, et al. (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42(suppl 5):1S\u201393S","journal-title":"J Nucl Med"},{"key":"9845_CR65","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00259-008-0818-x","volume":"35","author":"V Schick","year":"2008","unstructured":"Schick V, Franzius C, Beyna T, et al. (2008) Diagnostic impact of 18F-FDG PET\u2013CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound. Eur J Nucl Med Mol Imaging 35:1775\u20131785","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9845_CR66","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/SLA.0b013e3181b2fafa","volume":"250","author":"SP Kauhanen","year":"2009","unstructured":"Kauhanen SP, Komar G, Sepp\u00e4nem MP, et al. (2009) A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg 250:957\u2013963","journal-title":"Ann Surg"},{"key":"9845_CR67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1148\/radiology.192.1.8208970","volume":"192","author":"R Bares","year":"1994","unstructured":"Bares R, Klever P, Hauptmann S, et al. (1994) F18-fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 192:79\u201386","journal-title":"Radiology"},{"key":"9845_CR68","first-page":"678","volume":"24","author":"M Zimny","year":"1997","unstructured":"Zimny M, Bares R, Fass J, et al. (1997) Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 24:678\u2013682","journal-title":"Eur J Nucl Med"},{"key":"9845_CR69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000085347","volume":"22","author":"D Lytras","year":"2005","unstructured":"Lytras D, Connor S, Bosonnet L, et al. (2005) Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg 22:55\u201362","journal-title":"Dig Surg"},{"key":"9845_CR70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1148\/radiology.195.2.7724751","volume":"195","author":"T Inokuma","year":"1995","unstructured":"Inokuma T, Tamaki N, Torizuka T, et al. (1995) Evaluation of pancreatic tumors with positron emission tomography and F-18 18 fluorodeoxyglucose: comparison with CT and US. Radiology 195:345\u2013352","journal-title":"Radiology"},{"key":"9845_CR71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02987835","volume":"15","author":"K Koyama","year":"2001","unstructured":"Koyama K, Okamura T, Kawabe J, et al. (2001) Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med 15:217\u2013224","journal-title":"Ann Nucl Med"},{"key":"9845_CR72","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/01.mcg.0000225672.68852.05","volume":"40","author":"S Bang","year":"2006","unstructured":"Bang S, Chung HW, Park SW, et al. (2006) The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. J Clin Gastroenterol 40:923\u2013929","journal-title":"J Clin Gastroenterol"},{"key":"9845_CR73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yasu.2010.05.007","volume":"44","author":"OK Serrano","year":"2010","unstructured":"Serrano OK, Chaudhry MA, Leach SD (2010) The role of PET scanning in pancreatic cancer. Adv Surg 44:313\u2013325","journal-title":"Adv Surg"},{"issue":"2","key":"9845_CR74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3748\/wjg.v17.i2.231","volume":"17","author":"S Okano","year":"2011","unstructured":"Okano S, Kakinoki K, Akamoto S, et al. (2011) 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer. World J Gastroenterol 17(2):231\u2013235","journal-title":"World J Gastroenterol"},{"key":"9845_CR75","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00534-007-1339-x","volume":"15","author":"S Seo","year":"2008","unstructured":"Seo S, Doi R, Machimoto T (2008) Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg 15:634\u2013639","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"9845_CR76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.gcb.2009.04.014","volume":"34","author":"C Pery","year":"2010","unstructured":"Pery C, Maurette G, Ansequer C, et al. (2010) Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions. Gastroenterol Clin Biol 34:465\u2013474","journal-title":"Gastroenterol Clin Biol"},{"key":"9845_CR77","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/RLU.0b013e3181e4da32","volume":"35","author":"HS Hong","year":"2010","unstructured":"Hong HS, Yun M, Cho A, et al. (2010) The utility of F18 FDG PET\/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clin Nucl Med 35:776\u2013779","journal-title":"Clin Nucl Med"},{"issue":"1","key":"9845_CR78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gassur.2004.10.002","volume":"9","author":"C Sperti","year":"2005","unstructured":"Sperti C, Pasquali C, Decet G, et al. (2005) F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. J Gastrointest Surg 9(1):22\u201328","journal-title":"J Gastrointest Surg"},{"key":"9845_CR79","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2967\/jnumed.108.054924","volume":"49","author":"M Fassan","year":"2008","unstructured":"Fassan M, Pizzi S, Sperti C, et al. (2008) 18F-FDG PET findings and GLUT-1 expression in IPMNs of the pancreas. J Nucl Med 49:2070","journal-title":"J Nucl Med"},{"key":"9845_CR80","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/SLA.0b013e31815c2a29","volume":"246","author":"C Sperti","year":"2007","unstructured":"Sperti C, Bissoli S, Pasquali C, et al. (2007) 18-Fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 246:932\u2013939","journal-title":"Ann Surg"},{"issue":"3","key":"9845_CR81","first-page":"613","volume":"24","author":"Y Tomimaru","year":"2010","unstructured":"Tomimaru Y, Takeda Y, Tatsumi M, et al. (2010) Utility of 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas. Oncol Rep 24(3):613\u2013620","journal-title":"Oncol Rep"},{"key":"9845_CR82","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00259-004-1656-0","volume":"32","author":"A Lyshchik","year":"2005","unstructured":"Lyshchik A, Higashi T, Nakamoto Y, et al. (2005) Dual phase 18F-fluoro-2-deoxy-d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging 32:389\u2013397","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9845_CR83","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1440-1746.2011.06625.x","volume":"26","author":"NQ Nguyen","year":"2011","unstructured":"Nguyen NQ, Bartholomeusz DF (2011) 18F-FDG-PET\/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed? J Gastroenterol Hepatol 26:613\u2013618","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"9845_CR84","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3748\/wjg.14.64","volume":"14","author":"H Wakabayashi","year":"2008","unstructured":"Wakabayashi H, Nishiyama Y, Otani T, et al. (2008) Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 14(1):64\u201369","journal-title":"World J Gastroenterol"},{"key":"9845_CR85","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2967\/jnumed.108.051466","volume":"49","author":"K Strobel","year":"2008","unstructured":"Strobel K, Heinrich S, Bhure U, et al. (2008) Contrast-enhanced 18F-FDG PET\/CT: 1-stop-shop imaging for assessing the respectability of pancreatic cancer. J Nucl Med 49:1408\u20131413","journal-title":"J Nucl Med"},{"key":"9845_CR86","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02985577","volume":"19","author":"Y Nishiyama","year":"2005","unstructured":"Nishiyama Y, Yamamoto Y, Yokoe K, et al. (2005) Contribution of whole body FDG-PET to the detection of distant metastases in pancreatic cancer. Ann Nucl Med 19:491\u2013497","journal-title":"Ann Nucl Med"},{"key":"9845_CR87","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.sla.0000172095.97787.84","volume":"242","author":"S Heinrich","year":"2005","unstructured":"Heinrich S, Goerres GW, Schafer M, et al. (2005) Positron emission tomography\/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 242:235\u2013243","journal-title":"Ann Surg"},{"key":"9845_CR88","first-page":"250","volume":"40","author":"A Frohlich","year":"1999","unstructured":"Frohlich A, Diederichs CG, Staib L, et al. (1999) Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 40:250\u2013255","journal-title":"J Nucl Med"},{"key":"9845_CR89","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2169\/internalmedicine.48.2009","volume":"48","author":"M Kuwatani","year":"2009","unstructured":"Kuwatani M, Kawakami H, Eto K, et al. (2009) Modalities for evaluating chemotherapeutic efficacy and survival time in patients with advanced pancreatic cancer: comparison between FDG-PET, CT, and serum tumor markers. Intern Med 48:867\u2013875","journal-title":"Intern Med"},{"issue":"3","key":"9845_CR90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1054\/bjoc.2000.1166","volume":"83","author":"NR Maisey","year":"2000","unstructured":"Maisey NR, Webb A, Flux GD, et al. (2000) FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer 83(3):287\u2013293","journal-title":"Br J Cancer"},{"key":"9845_CR91","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000085281","volume":"5","author":"J Ruf","year":"2005","unstructured":"Ruf J, Lopez Hanninen E, Oettle H, et al. (2005) Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT\/RM. Pancreatology 5:266\u2013272","journal-title":"Pancreatology"}],"container-title":["Abdominal Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-012-9845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-012-9845-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-012-9845-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:17:10Z","timestamp":1558700230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-012-9845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,13]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9845"],"URL":"https:\/\/doi.org\/10.1007\/s00261-012-9845-y","relation":{},"ISSN":["0942-8925","1432-0509"],"issn-type":[{"value":"0942-8925","type":"print"},{"value":"1432-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,13]]}}}